Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Department of Justice
Mallinckrodt
Federal Trade Commission
Merck
Accenture
Express Scripts
Moodys
Farmers Insurance

Generated: February 17, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for CHOLESTYRAM

« Back to Dashboard

Payment Methods and Pharmacy Types for CHOLESTYRAM (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $2,521,706
INSIDE ANOTHER STORE $13,205,952
[disabled in preview] $75,841,958
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 31,372
INSIDE ANOTHER STORE 170,502
[disabled in preview] 443,366
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $4,508,926
MEDICARE $7,908,041
[disabled in preview] $79,152,650
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for CHOLESTYRAM
Drug Units Sold Trends for CHOLESTYRAM

Annual Sales Revenues and Units Sold for CHOLESTYRAM

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
CHOLESTYRAM ➤ Sign Up ➤ Sign Up 2016
CHOLESTYRAM ➤ Sign Up ➤ Sign Up 2015
CHOLESTYRAM ➤ Sign Up ➤ Sign Up 2014
CHOLESTYRAM ➤ Sign Up ➤ Sign Up 2013
CHOLESTYRAM ➤ Sign Up ➤ Sign Up 2012
CHOLESTYRAM ➤ Sign Up ➤ Sign Up 2011
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Cipla
Express Scripts
Covington
Argus Health
Boehringer Ingelheim
Chinese Patent Office
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.